About A*STAR
About A*STAR
A*STAR Horizontal Technology Programme Offices (HTPO)
Corporate Profile
A*STAR Board
Senior Management
Organisation Structure
Corporate Social Responsibility
Biomedical Research Council
Science and Engineering Research Council
About A*STAR Future of Manufacturing Initiative
Enterprise (Commercialisation and Technology Transfer)
A*STAR Graduate Academy (A*GA)
Research Entities
Research
About A*STAR Research
Research Focus
Chemicals, Materials and GreenTech
Electronics
Engineering
Infocomms
Food and Consumer
Medical Technology
Pharmaceuticals & Biologics
Robotics and Automation
Security and Transport
Biomanufacturing
Research Entities Capabilities
Biomedical Research
Science and Engineering Research
Funding Opportunities
Research Quality Excellence
Research Ethics
Open Access Policy
Research Resource Portal
Science Outreach
A*STAR Research Publications
FusionWorld
President Science and Technology Awards
Young Scientist Awards
Our People
Honours and Accolades
Distinguished Visitor Programme
Collaborate
About A*STAR Collaboration
Industry Sectors
Chemical and Energy
Electronics
Engineering
Food, Nutrition and Consumer Care
Infocomms
Medical Technology
Pharmaceuticals & Biologics
Collaboration Models
Programmes for SMEs
Tech Access
Operation & Technology Roadmap
Technical Capability Upgrade
Technology for Enterprise Capability Upgrading
T-Up Excellence Awards
A*STAR Patents
From lab to market
Innovation Partnering
Enhancing the ecosystem for technopreneurship
Scholarships
About A*STAR Scholarships
For Undergraduate studies
Overview
A*STAR Research Internship Award (ARIA)
National Science Scholarship (BS)
Singapore International Pre-Graduate Award (SIPGA)
For Graduate Studies
Overview
National Science Scholarship (Masters)
National Science Scholarship (PhD)
A*STAR CIS Scholarship
A*STAR Graduate Scholarship (Singapore)
A*STAR-University of Warwick (AWP) EngD Partnership
Singapore International Graduate Award (SINGA)
A*STAR Research Attachment Programme (ARAP)
For Post doctoral Studies
Overview
A*STAR International Fellowship
A*STAR Graduate Scholarship (Post-Doc)
Junior College and Polytechnic and Secondary School Students
Overview
A*STAR Science Award (Upper Sec)
A*STAR Science Award (JC)
A*STAR Science Award (Poly)
H3 Attachment
A*STAR - MOE Attachment
Information on Research Attachments at A*STAR RIs
Our Scholars
Overview
Featured Scholars
Scholarship Awardees
Scholars' Honours List
Developmental Opportunities for Scholars
News and Events
A*STAR News
A*STAR Innovate
Faces of A*STAR
A*STAR TV
Discover Science
Business Insider
A*STAR Publications
A*STAR Talent Times
Subscribe
Events
Career
Search
Home
IMCB
IMCB Research
Joint Programmes
IMCB
About Us
History
IMCB SAB
Leaders
Awards and Accolades
Graduate Students
Grants
IMCB Research
Scientific Programmes
Neurometabolism in Health & Diseases
Cancer Signaling & Therapies
Cell Biology & Therapies
Innovative Technologies
Disease Intervention Technology Lab
Molecular Engineering Lab
Technology Platform, Operation & Support
Joint Programmes
Joint PIs
Adjunct PIs
Career
News Room
2021 - News Headline
2020 - News Headline
2019 - News Headline
Events
IMCB Event
Internal Event
External Event
Biopolis Event
Intranet
Webmail
IMCB Partners
Contact Us
Joint Programmes
SERI-IMCB Programme On Retinal Angiogenic Diseases (SIPRAD)
IMCB-NCCS Joint Programme
Kanagas SABAPATHY
Molecular Carcinogenesis
Pierce CHOW
PuRPOSE programme
Kam Man HUI
Human Cancer Genomics and Therapeutics
Bin Tean TEH
Chromatin Therapeutics
Huynh The HUNG
IMCB-NCC MPI Singapore Oncogenome Programme
Darren Wan-Teck LIM
IMCB NCC MPI Singapore Oncogenome Program
SingHealth @ IMCB Fellows
Joanne NGEOW
Brief Biosketch
Wan Yee TEO
Lab Unit of Paediatric Brain Tumour Research Office
Kanagas SABAPATHY
close
Kanagas SABAPATHY
Molecular Carcinogenesis
The Sabapathy lab is focused (i) on understanding the mechanistic basis of cellular transformation and resistance to cancer therapy, by investigating the key p53/p73 tumor-suppressor pathway, so as to generate novel therapeutic strategies; and (ii) on developing mouse models to best reflect various cancer types to study the carcinogenic process.
Cancer genome sequencing efforts have led to the identification of major alterations that occur in a wide variety of genes. Moreover, expression analyses have also revealed differences in many key genes that have been suggested to regulate the tumorigeneic process and response to therapy. Of these, some – especially those that code for enzymes - have been deemed “druggable” and hence, intensely pursued, albeit being of relevance to a small population. On the other hand, many genes have not received significant attention from the drug discovery perspective, simply due to the perception that they are “undruggable”. One such gene family is the p53 family of tumor suppressors, which are transcription factors. Whilep53is the most mutated gene in cancers, its homologuep73is often overexpressed in cancers. Large amount of data exist to demonstrate the role of mutant p53 and overexpressed p73 in tumor promotion and resistance to therapy. While these molecules could be potential therapeutic targets of enormous benefit to patients, they have not been subjected to major drug discovery efforts due to the difficulties in targeting transcription factors.
Research
Publication
Pierce CHOW
close
Pierce CHOW
PuRPOSE programme
Brief Biosketch
Pierce Chow is an academic surgeon and Professor at the Duke-NUS Medical School. He is concurrently Senior Consultant Surgeon at the National Cancer Centre Singapore and the Singapore General Hospital, NMRC Senior Clinician Scientist, Adjunct Faculty at the Genome Institute of Singapore and Research Director at the Institute of Cellular and Molecular Biology. He trained in Liver Transplantation with Professor Russell Strong in Australia. In 1998, he co-founded the Asia-Pacific Hepatocellular Carcinoma (AHCC) Trials Group and has been the protocol chair of 5 multi-center clinical trials that have involved more than 30 centers in 14 countries. He was conferred the NMRC National Outstanding Clinician Scientist Award for improving clinical outcomes with his research on Liver Cancer in 2012.
Prof Chow was awarded the NMRC grant for the Translational and Clinical Research (TCR) Flagship Program in Liver Cancer in 2016. Building on positive results of earlier genetic and immunology studies in surgically resected HCC, Prof Chow now leads a multi-national study on how genomic heterogeneity and the immune micro-environment in HCC impact clinical outcomes. The Program will identify clonally dominant drivers, bring precision medicine to individuals with HCC and initiate new multi-national clinical studies across the Asia Pacific to advance treatment strategies for HCC. In 2017 Prof Chow was awarded the BMRC IAF-PP Grant to develop a patient-specific diagnostic and predictive platform for Precision Medicine in HCC.
Research
Kam Man HUI
close
Kam Man HUI
Human Cancer Genomics and Therapeutics
Professor Hui Kam Man is currently serving as Deputy Group Director (Translational Research) at SingHealth. He is also a Principal Investigator at the Division of Cellular and Molecular Research, National Cancer Centre Singapore. In addition, he holds Adjunct Professorships with the Program in Cancer & Stem Cell Biology, Duke-NUS Graduate Medical School and the Dept of Biochemistry, Yong Loo Lin School of Medicine. Besides being a Joint Research Director at the Institute of Molecular and Cell Biology (IMCB), Prof. Hui also holds an Adjunct Senior Investigator position at the Singapore BioImaging Consortium (SBIC), A*STAR.
Prof. Hui, a Singaporean, received his BSc and MSc from the Dept of Bacteriology & Public Health, Washington State University, Pullman, USA and his PhD in Immunology, Northwestern University School of Medicine, Chicago, U.S.A. Prior to Singapore, Prof. Hui was employed at the Royal London Hospital, Whitechapel Road, London; and as a scientific member at the MRC National Institute for Medical Research, Mill Hill, London, United Kingdom. Prof Hui was awarded the Fellowship of The Royal College of Pathologists, FRCPath (UK) in 2001 and the Singapore National Science Award (now the President's Science Award) in 1996 for his work in cancer genes and therapy.
Research
Publication
Bin Tean TEH
close
Bin Tean TEH
Chromatin Therapeutics
Lab Location:
#7-18
Email:
btteh@imcb.a-star.edu.sg
Tel:
65869560
Dr Bin Tean Teh obtained his MD (1992) from the University of Queensland, Australia and his PhD (1997) from the Karolinska Institute, Sweden. Following postdoctoral works in multiple endocrine neoplasia 1 at Karolinska Institute, Dr Teh joined the Van Andel Research Institute (VARI) in 2000 as a Senior Scientific Investigator heading the Laboratory of Cancer Genetics. In 2007, Dr Teh was appointed as the founding Director of the National Cancer Centre Singapore (NCCS)-VARI laboratory, which serves as a bridge between translational research and clinical medicine. In 2010 he received the STaR award and relocated to Singapore and is currently a full professor in CSCB. He served as the SingHealth Group Director for Translational Research from 2010-2012. His laboratory focuses on genomic studies of cancers common among Asian populations, using tools such as high-throughput genomic platforms and correlation studies with cliinico-pathological information. He holds Adjunct Professorships at several universities worldwide including Baylor College of Medicine, USA, Nanjing University and Sun Yat-Sen University, China and the Karolinska Institute, Sweden. Dr. Teh has published extensively, with over 300 publications in high impact scientific journals. He has been member of various editorial boards for journals including Lancet Oncology, Cancer Research, Molecular Cancer Therapeutics, International Journal of Oncology, Journal of Clinical Endocrinology and Metabolism, Clinical Genitourinary Cancer, and the American Journal of Translational Research.
Research
Publications
Darren Wan-Teck LIM
close
Darren Wan-Teck LIM
IMCB NCC MPI Singapore Oncogenome Program
Dr Darren Wan-Teck Lim is a medical oncologist. He graduated with MBBS from the National University of Singapore in 1993. He is Director of the SingHealth Investigational Medicine Unit. He was a visiting research fellow in pharmacogenomics and thoracic oncology at the Washington University School of Medicine, St Louis. His research interests are in early phase clinical trials with biomarker correlates, with areas of specific interest in circulating tumor cells. He is also Co-Group Leader for the laboratory
Research
Publication
Joanne NGEOW
close
Joanne NGEOW
Brief Biosketch
Brief Biosketch
Associate Professor Joanne Ngeow, is a Senior Consultant in Division of Medical Oncology at the National Cancer Centre Singapore (NCCS). Assoc Prof Ngeow currently heads the NCCS Cancer Genetics Service with an academic interest in hereditary cancer syndromes and translational clinical cancer genomics. Her current clinical focus and research revolves around understanding cancer predisposition by studying cancers clustering in families, young adults and in families with multiple / rare cancer presentations.
After completing her undergraduate medical studies at the University of Melbourne, Australia, in 2001, she completed her Internal Medicine training at the Singapore General Hospital and trained in Medical Oncology at NCCS. She was awarded consecutive fellowships by the SingHealth Research Foundation, National Medical Research Council and the Ambrose Monell Foundation to complete formal clinical and bench training as the Ambrose Monell Cancer Genomic Medicine Fellow at the Genomic Medicine Institute, Cleveland Clinic, Ohio. In 2015, she completed her Masters of Public Health at the Bloomberg School of Public Health, Johns Hopkins University, with a focus in cancer epidemiology and health economics making her one of a handful of individuals globally with skills spanning translational science, clinical genetics and health services research.
In 2014, Assoc Prof Ngeow returned to Singapore to lead the clinical cancer genetics service and research programme at NCCS into inherited cancer syndromes. Assoc Prof Ngeow was appointed as Associate Professor (Genomic Medicine) of Lee Kong Chian School of Medicine, Nanyang Technological University in 2017. She has published over 80 peer reviewed papers in such journals as the
Journal of Clinical Oncology, Annals of Oncology, Human Molecular Genetics, Journal of Clinical Endocrinology and Metabolism, Gastroenterology. She is an Associate Editor for Endocrine-Related Cancers
.
Research
Wan Yee TEO
close
Wan Yee TEO
Lab Unit of Paediatric Brain Tumour Research Office
Dr. Wan-Yee Teo, a clinician-scientist, is the Principal Investigator of the Pediatric Brain Tumor Research Office at SingHealth Duke-NUS Academic Medical Center, Singapore. Her group conducts their laboratory research at the Humphrey Oei Institute of Cancer Research, National Cancer Center Singapore. The research focus of her group is in the brain tumor microenvironment, particularly in pediatric brain tumors, and translating research findings in tumor biology and genomics to bedside benefits for children with brain tumors. She completed her clinical training in Pediatrics and Pediatric NeuroOncology in the USA, and is board certified with the American Board of Pediatrics, and the Royal College of Pediatrics and Child Health in the UK. Her research training was completed in the Cancer Genomics Program at Baylor College of Medicine, USA. Her research combines genomic methodologies and mouse models to study the complex regulation in the developmental biology of brain tumors.
Affiliations:
Wan-Yee Teo, MBBS, FAAP, MRCPCH (UK), FAMS, PhD.
Assistant Professor | Duke-NUS Medical School | Cancer & Stem Cell Biology Program
Assistant Professor | Duke-NUS Medical School l Medical Education, Research & Evaluation Department
Course Director, Practice Course 4 | Duke-NUS Medical School l Medical Education, Research & Evaluation Department
Principal Investigator | Pediatric Brain Tumor Research Office | SingHealth Duke-NUS Academic Medical Center
Clinician-Scientist | Humphrey Oei Institute of Cancer Research | National Cancer Center Singapore | KK Women's & Children's Hospital
Research Clinician | Institute of Molecular & Cell Biology | A*STAR, Singapore
Adjunct Assistant Professor | Department of Pediatrics | Section of Hematology-Oncology | Texas Children’s Cancer Center | Baylor College of Medicine
Research
Team members